Document Type : Full Research Paper


1 M.Sc Student of Materials Engineering, Ceramics Department, Materials and Energy Research Center

2 Assistant Professor, Ceramics Department, Materials and Energy Research Center



The aim of the present paper is to investigate the effect of incorporating various amounts of strontium ions (0.19 - 2.23 wt%) into calcium sulfate bio ceramics on the physical, structural properties and in vitro bioactivity and compare these properties with those of a pure calcium sulfate dehydrate (gypsum) as control. Strontium-doped gypsum (Sr-gypsum) was obtained by mixing calcium sulfate hemihydrates powder and solutions of strontium nitrate followed by washing the specimens with distilled water for the removal of residual salts. Gypsum was the only phase found in the composition of both pure and Sr-gypsum meanwhile a shift into lower diffraction angles was observed in the x-ray diffraction patterns of doped specimens. The Sr-doped sampled exhibited higher compressive strength and lower solubility than pure gypsum. Microstructure of all gypsum specimens had been composed of many rod-like small crystals entangled to each others with more elongation and higher thickness in the cases of Sr-gypsum. EDXA pattern of Sr-gypsum showed the presence of calcium and sulfur ions as the main elements of gypsum as well as slight amount of strontium ion. A continuous release of strontium was observed from the Sr-gypsum after soaking in simulated body fluid for 14 days. Proliferation rate of cultured osteoblasts and higher alkaline phosphatase activity on doped samples was better compared to pure gypsum.


Main Subjects

[1]     Dahl S.G., Allain P., Marie P.J., Mauras Y., Boivin G., Ammann P., Tsouderos Y., Delmas P.D., Christiansen C., Incorporation and distribution of strontium in bone, Bone 2001; 28: 446–53.
[2]     Pors Nielsen S., The biological role of strontium, Bone, 2004; 35: 583–8.
[3]     Rizzoli R., A new treatment for post-menopausal osteoporosis: strontium ranelate, J. Endocrinol. Invest, 2005; 28: 50–7.
[4]     Marie J.P., Ammann P., Boivin G., Rey C., Mechanisms of action and therapeutic potential of strontium in bone, Calcif. Tissue. Int., 2001; 69: 121– 9.
[5]     Suzuki O., Imaizumi H., Kamakura S., Katagiri T., Bone regeneration by synthetic octacalcium phosphate and its role in biological mineralization, Curr. Med. Chem., 2008; 15: 305-13.
[6]     Huan Z., Chang J., Calcium-phosphate-silicate composite bone cement: selfsetting properties and in vitro bioactivity, J. Mate. Sci. Mater. Med., 2009; 20: 833-41.
[7]     Yu T., Ye J., Wang Y., Synthesis and property of a novel calcium phosphate cement, J. Biomed. Mater. Res. B Appl. Biomater., 2009; 90: 745-51.
[8]     Bigi A., Foresti M., Gandolfi M., Gazzano M., Roveri N., Isomorphous substitutions in b-tricalcium phosphate: the different effects of zinc and strontium, J. Inorg. Biochem., 1997; 66: 259–65.
[9]     Saint-Jean S.J, Camire C.L., Nevsten P., Hansen S., Ginebra M.P., Study of the reactivity and in vitro bioactivity of Sr substituted alpha-TCP cements, J. Mater. Sci. Mater. Med., 2005; 16: 993–1001.
[10] Li Y.W., Leong J.C.Y., Lu W.W., Luk K.D.K., Cheung K.M.C., Chiu K.Y., Chow S.P., A novel injectable bioactive bone cement for spinal surgery: a developmental and preclinical study, J. Biomed. Mater. Res., 2000; 52: 164–70.
[11] Guo D., Xu K., Zhao X., Han Y., Development of a strontium-containing hydroxyapatite bone cement, Biomaterials, 2005; 26: 4073–83.
[12] Cheung K.M.C., Lu W.W., Luk K.D.K., Wong C.T., Chan D., Shen J.X., Qiu G.X., Zheng Z.M., Li C.H., Liu S.L., Chan W.K., Leong J.C., Vertebroplasty by use of a strontium-containing bioactive bone cement,  Spine, 2005; 30: S84–91.
[13] Wong C.T., Lu W.W., Chan W.K., Cheung K.M.C., Luk K.D.K., Lu D.S., et al., In vivo cancellous bone remodeling on a strontium-containing hydroxyapatite (Sr- HA) bioactive cement, J. Biomed. Mater. Res., 2004; 68A: 513–21.
[14] Xue W., Hosick H.L., Bandyopadhyay A., Bose S., Ding C., Luk K.D.K., Cheunge K.M.C., Lue W.W., Preparation and cell-materials interactions of plasma sprayed strontium-containing hydroxyapatite coating, Surf. Coating Technol., 2007; 201: 4685–93.
[15] Abou Nell E.A., Chrzanowski W., Pickup D.M., O'Dell L.A., Mordan N.J., Newport R.J., Smith M.E., Knowles J.C., Structure and properties of strontiumdoped phosphate-based glasses, J. Roy. Soc. Inter., 2009; 6: 435- 46.
[16] Hesaraki S., Alizadeh M., Nazarian H., Sharifi D., Physico-chemical and in vitro biological evaluation of strontium/calcium silicophosphate glass, J. Mater. Sci. Mater. Med., 2009 (In press, doi: 10.1007/s10856-009- 3920-0).
[17] Anson D., Using calcium sulfate in guided tissue regeneration: a recipe for success, Compend. Contin. Educ. Dent., 2000; 21: 365-70.
[18] Bier S.J., Sinensky M.C., The versatility of calcium sulfate: resolving periodontal challenges, Compend. Contin. Educ. Dent., 1999; 20: 655-61.
[19] Pecora G., Andreana S., Margarone J.E., Covani U., Sottosanti J.S., Bone regeneration with a calcium sulfate barrier, Oral. Radiol Endod., 1997; 84: 424- 9.
[20] Paderni S., Terzi S., Amendola L., Major bone defect treatment with an osteoconductive bone substitute, Musculoskelet Surg., 2009; 93: 89-96.
[21] Lazáry A., Balla B., Kósa J.P., Bácsi K., Nagy Z., Takács I., Varga P.P., Speer G., Lakatos P., Effect of gypsum on proliferation and differentiation of MC3T3- E1 mouse osteoblastic cells, Biomaterials, 2007; 28: 393-9.
[22] Kokubo T., Kushitani H., Sakka S., Kitsugi T., Yamamuro T.J., Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic AW, J. Biomed. Mater. Res., 1990; 24: 721–34.
[23] Hesaraki S., Moztarzadeh F., Nezafati N., Evaluation of a bioceramic-based nanocomposite material for controlled delivery of a non-steroidal anti-inflammatory drug, Med. Eng. Phys., 2009 (In press, doi:10.1016/j.medengphy.2009.07.019).
[24] Fourman P., Royer P., Levell M., Morgan D.B., Calcium metabolism and the bone, 2nd ed., Oxford: Blackwell, 1968.
[25] Hesaraki S., Moztarzadeh F., Nemati R., Nezafati N., Preparation and characterization of calcium sulfatebiomimetic apatite nanocomposites for controlled release of antibiotics, J. Biomed. Mater. Res. B (Appl. Biomater., 2009; 91: 651-61.
[26] Alkhraisat M., Moseke C., Blanco L., Barralet J.E., Lopez-Carbacos E., Gbureck U., Strontium modified biocements with zero order release kinetics, Biomaterials, 2008; 29: 4691-7.
[27] Boyd D., Towler M.R., Watts S., Hill R.G., Wren A.W., Clarkin O.M., The role of Sr2+ on the structure and reactivity of SrO-CaO-ZnO-SiO2 ionomer glasses, J. Mater. Sci. Mater. Med., 2008; 19: 953-7.
[28] Raushmann M.A., Wichelhaus T.A., Stirnal V., Dingeldein E., Zichner L., Schnettler R., Alt V., Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections, Biomaterials, 2005; 26: 2677-84.
[29] Marie P.J., Ammann P., Boivin G., Rey C., Mechanisms of action and therapeutic potential of strontium in bone, Calcif. Tissue Int., 2001; 69: 121–9.
[30] Landi E., Tampieri A., Celotti G., Sprio S., Sandri M., Logroscino G., Sr-substituted hydroxyapatites for osteoporotic bone replacement, Acta Biomater., 2007; 3: 961–9.
[31] Xue W., Moore J.L., Hosick H.L., Bose S., Bandyopadhyay A., Lu W.W., et al., Osteoprecursor cell response to strontium containing hydroxyapatite ceramics, J. Biomed. Mater. Res., 2006; 79A: 804–14.
[32] Stein G.S., Lian J.B., Owen T.A., Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation, FASEB J, 1990; 4: 3111–23.
[33] Kim H.W., Koh Y.H, Kong Y.M, Kang J.G., Kim H.E., Strontium substituted calcium phosphate biphasic ceramics obtained by a powder precipitation method, J. Mater. Sci. Mater. Med., 2004; 15: 1129-34.